John V. Oyler

Biography

  Has served as CEO and Director since founding BeiGene in 2010 Founder & CEO of BioDuro, 700-person integrated research CRO in Beijing, sold to Pharmaceutical Product Development Inc. with attractive returns (2005-2009) CEO of Galenea, Boston biotech started from MIT with funding from Otsuka, (2002-2004) Founder, President of Telephia, sold to Nielsen (1997-2002) Co-CEO of Genta (GNTA), publicly-traded oncology company that grew in late ’90s to $1.7 billion in revenues (1997-1998) Began career at McKinsey & Company MBA from Stanford University B.S. from Massachusetts Institute of Technology

Research Interest

 Pharmaceutica Business, Pharmacology